FIELD: medicine.
SUBSTANCE: invention relates to the field of preventing the transmission of malaria and can be used to combat the spread of malaria. The following is provided: a method of reducing or preventing the transmission of malaria-causing parasites, comprising the step of bringing one or more mosquitoes into contact with bacteria of Delftia tsuruhatensis genus. The use of bacteria of Delftia tsuruhatensis genus has also been proposed to reduce the transmission of malaria. When introduced into mosquito-containing environments, Delftia tsuruhatensis bacteria prevent mosquito transmission of malaria-causing Plasmodium parasites by inhibiting Plasmodium ookinetes and oocysts in the mosquito midgut.
EFFECT: reduction of malaria transmission.
5 cl, 2 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
VIRUS-LIKE PARTICLES CONTAINING TARGET PROTEINS FUSED WITH COAT PROTEINS OF PLANT VIRUSES | 2010 |
|
RU2571223C2 |
PEPTIDE SEQUENCES AND PEPTIDE COMPOSITIONS | 2008 |
|
RU2466737C2 |
STRAIN OF BACTERIUM BACILLUS THURINGIENSIS VARIETAS ISRAELENSIS DESIGNATED FOR PREPARING A PREPARATION EXHIBITING ACTIVITY AGAINST MOSQUITO LARVAE | 1997 |
|
RU2122791C1 |
REGIMEN FOR TREATMENT WITH 2-AMINO-1-(2-(4-FLUOROPHENYL)-3-(4-FLUOROPHENYLAMINO)-8,8-DIMETHYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZINE-7 (8H)-YL)ETHENONE AND ITS COMBINATIONS | 2018 |
|
RU2791466C2 |
THERAPEUTIC ANTIMALARIA DRUG BASED ON ANTIMALARIA AGENT AND PROBIOTIC | 2010 |
|
RU2472505C2 |
COMBINATION OF QUINOLINE-4-CARBOXAMIDES AND BENZONAPHTHYRIDINE DERIVATIVES AS A COMBINED ANTIMALARIA MEDICINE | 2019 |
|
RU2806303C2 |
STRAIN OF BACTERIUM BACILLUS SPHAERICUS DESIGNATED FOR PREPARING THE PREPARATION AGAINST MOSQUITOS | 1994 |
|
RU2080066C1 |
VACCINES CONTAINING ANTIGEN Plasmodium | 2005 |
|
RU2423994C2 |
METHODS OF MALARIA VACCINATION | 2003 |
|
RU2356577C9 |
ANTIMALARIAL SYNERGISTIC COMPOSITION CONTAINING BENFLUMETHOL | 1993 |
|
RU2118158C1 |
Authors
Dates
2024-02-29—Published
2020-07-10—Filed